日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Biological characterization of breast cancer spheroid formed by fast fabrication method.

快速制备法形成的乳腺癌球体的生物学特性研究

期刊:
影响因子:
doi:10.1007/s44164-024-00066-3
Iijima Yuta, Uenaka Norino, Morimoto Mayu, Sato Daiki, Hirose Satomi, Sakitani Naoyoshi, Shinohara Masahiro, Funamoto Kenichi, Hayase Gen, Yoshino Daisuke
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Risk evaluation of denosumab and zoledronic acid for medication-related osteonecrosis of the jaw in patients with bone metastases: a propensity score-matched analysis

地诺单抗和唑来膦酸治疗骨转移患者药物相关性颌骨坏死的风险评估：倾向评分匹配分析

期刊:Supportive Care in Cancer
影响因子:3
doi:10.1007/s00520-021-06634-7
Ikesue, Hiroaki; Doi, Kohei; Morimoto, Mayu; Hirabatake, Masaki; Muroi, Nobuyuki; Yamamoto, Shinsuke; Takenobu, Toshihiko; Hashida, Tohru
发表日期：2022
文献求助 收藏

Immortalization of cells derived from domestic dogs through expressing mutant cyclin-dependent kinase 4, cyclin D1, and telomerase reverse transcriptase

通过表达突变型细胞周期蛋白依赖性激酶 4、细胞周期蛋白 D1 和端粒酶逆转录酶，使源自家犬的细胞永生化。

期刊:Cytotechnology
影响因子:2
doi:10.1007/s10616-021-00504-0
Izzah Munirah,Taku Ozaki,Aya Sekine,Motoko Morimoto,Mayu Sugawara,Haruka Takada,Eriko Sugano,Hiroshi Tomita,Tohru Kiyono,Tomokazu Fukuda
细胞生物学
发表日期：2022
文献求助 收藏

Switching from zoledronic acid to denosumab increases the risk for developing medication-related osteonecrosis of the jaw in patients with bone metastases

对于骨转移患者，从唑来膦酸换用地诺单抗会增加发生药物相关性颌骨坏死的风险。

期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.3
doi:10.1007/s00280-021-04262-w
Ikesue, Hiroaki; Doi, Kohei; Morimoto, Mayu; Hirabatake, Masaki; Muroi, Nobuyuki; Yamamoto, Shinsuke; Takenobu, Toshihiko; Hashida, Tohru
发表日期：2021
文献求助 收藏

Revolver is a new class of transposon-like gene composing the triticeae genome

Revolver是小麦族基因组中一类新型的转座子样基因。

期刊:DNA Research
影响因子:2.9
doi:10.1093/dnares/dsm029
Tomita, Motonori; Shinohara, Kasumi; Morimoto, Mayu
发表日期：2008
文献求助 收藏